Tagged: GILD

Stocks Headed for a Mixed Finish

Stocks are headed for a mixed finish in trading today as investors remain on the sidelines ahead of the crucial euro zone finance ministers meeting on Monday. At last check, the Dow Jones was...

Stocks Rally on Strong Jobs Report

Stocks rose sharply in trading today as a better than expected jobs report lifted investors’ sentiment. According to figures released by the Labor Department earlier today, the U.S. economy added 243,000 jobs in the...

Gilead Sciences to Acquire Pharmasset (GILD, VRUS)

Gilead Sciences Inc. (NASDAQ: GILD), a biopharmaceutical company engaged in the development and commercialization of human therapeutics for life threatening diseases, today entered into a definitive agreement with Pharmasset Inc. (NASDAQ: VRUS) under which...

Gilead Obtaining Approval for HIV Drug

Gilead Sciences (NASDAQ:GILD) has asked the Food and Drug administration to approve its HIV treatment drug for AIDS. The single pill treatment for AIDS is a combination of the two proprietary drugs Tibotec and...